Researchers at the Icahn School of Medicine at Mount Sinai have developed an advanced artificial intelligence (AI)-driven tool to improve the management and prognosis of prostate cancer. Recent ...

Imagine a future where the moment you’re born, a virtual avatar is created and steadily filled with personalised information ...

In an analysis of more than half a million men with hypogonadism, testosterone replacement therapy is tied to a 16% lower ...

Minimally invasive therapy has fewer side effects, hospital says Columbia Memorial Hospital is expanding its robotic-assisted ...

In the modern era of advanced imaging and genomics testing, the digital rectal exam (DRE) is still an "important" and clinically relevant prognostic test for prostate cancer, conclude the authors of a ...

Researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University have preliminarily validated an artificial intelligence (AI) tool to predict ...

A polygenic risk score was able to detect a high proportion of clinically significant prostate cancer. Cancer would not have been detected in 71.8% of patients with the use of PSA or MRI screening.

The study found that patients with luminal B subtype prostate cancer benefited from the addition of hormone therapy to ...

New technologies and treatment methods are expanding men’s options. Here’s what you should know about your choices for ...

Five-year survival rates for prostate cancer are notably high. Johns Hopkins Medicine notes that approximately 80 to 85% of all prostate cancers are detected in the local or regional stages, which ...